Skip to main content
Clinical Trials/NCT04203979
NCT04203979
Recruiting
Not Applicable

Sepsis: From Syndrome to Personalized Care

Oslo University Hospital1 site in 1 country1,500 target enrollmentJanuary 6, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis Syndrome
Sponsor
Oslo University Hospital
Enrollment
1500
Locations
1
Primary Endpoint
Area under the curve receiver operator characteristic (AUC - ROC) for inflammation biomarkers for detecting infection in critically ill patients.
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This is a prospective, observational study designed to examine the performance of biomarkers, molecular biological methods and other analysis in blood from patient with suspected sepsis in the Emergency department, as well as identidying novel sepsis endotypes. Around 1500 patients will be enrolled.

Detailed Description

The study will prospectively include adult patients (\>18 years) with suspected sepsis admitted to Oslo University Hospital, Ullevål (OUH-Ullevål). Patients admitted to the emergency department and managed by the medical rapid response team or the sepsis rapid response team are considered eligible for inclusion. Informed consent will be collected at the emergency department if possible, or within few days, by a clinical investigator or a study nurse. The investigators aim to include 1500 patients treated by the Sepsis Rapid Response Team or Medical Emergency team for possible sepsis. Patients classified to have had other conditions than sepsis in the post hoc assessment will be used as controls. The inclusion period will be 3 years.

Registry
clinicaltrials.gov
Start Date
January 6, 2020
End Date
December 31, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Oslo University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Aleksander Rygh Holten

Principal Investigator

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • admitted to emergency department OUH, Ullevål.
  • managed by the medical rapid response team or the sepsis rapid response team

Exclusion Criteria

  • Not given informed consent by patient or next of kin (if patient is not able to)

Outcomes

Primary Outcomes

Area under the curve receiver operator characteristic (AUC - ROC) for inflammation biomarkers for detecting infection in critically ill patients.

Time Frame: One year

Comparing area under the curve receiver operator characteristic (AUC - ROC) for calprotectin, pro-calcitonin, CRP and other biomarkers for detecting infections in critically ill patients in the Emergency department.

Number of sepsis patient with bacterial DNA detected in blood by molecular biological tests.

Time Frame: One year

The performance of rapid molecular biological tests for detecting bacterial DNA in full blood in critically ill medical patients, compared to current state-of-the art diagnostics (blood culture).

Number of sepsis patient with elevated plasma-calprotectin

Time Frame: One year

Sensitivity of plasma-calprotectin for detecting infections in critical ill medical patients in the Emergency department.

Secondary Outcomes

  • Concentration of biomarkers in blood.(One year)

Study Sites (1)

Loading locations...

Similar Trials